Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplantation (University of Calgary)
- Development stage
- Unknown
- Lead developer
- Taylored Biotherapeutics
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Fecal microbiota transplantation (FMT) is an investigational live biotherapeutic therapy being studied for psychiatric and gastrointestinal disorders. [8] It involves transferring gut bacteria and other microbes from a healthy, screened donor to a patient's gut, with the goal of restoring a balanced microbial community. [8] This approach is based on the growing understanding of the microbiome-gut-brain axis, a communication pathway that links the gut and the brain. [2, 9] Research led by Dr. Valerie Taylor at the University of Calgary is specifically evaluating the effectiveness, safety, and tolerability of oral FMT (in capsule form) for adults with Major Depressive Disorder (MDD), including those with co-occurring Irritable Bowel Syndrome (IBS). [2, 3] A Phase 2/3 clinical trial is underway to assess if modulating the gut microbiome with FMT can alleviate symptoms of depression and IBS. [3, 14]
- Other names
- fecal microbiota transplantFMTpoop pills
Beyond the preview
Go deeper on fecal microbiota transplantation (University of Calgary).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplantation (University of Calgary).